Follicular Lymphoma in a Single Cancer Center and Validation of FLIPI, FLIPI2, PRIMA and POD24 in Non- Caucasian Patients from Peru

被引：0
|
作者：
Vasquez, Jule F. [1 ]
Diaz, Alonso [2 ]
Mendoza, Any S. [3 ]
Barrionuevo, Carlos [4 ]
Samanez-Figari, Cesar [2 ]
机构：
[1] Inst Nacl Enfermedades Neoplas, Dept Med Oncol, Lima, Peru
[2] Oncosalud AUNA, Lima, Peru
[3] Univ Nacl Mayor San Marcos, Lima, Peru
[4] Inst Nacl Enfermedades Neoplas, Dept Pathol, Lima, Peru
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149734
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4518
引用
收藏
页数：3
相关论文
共 9 条
  • [1] Validation of FLIPI1, FLIPI2, PRIMA and POD24 in Patients with Extranodal Follicular Lymphoma: A Cohort from Two Cancer Centers in Peru
    Vasquez, Jule F.
    Diaz, Alonso
    Mendoza, Any S.
    Barrionuevo, Carlos
    Samanez-Figari, Cesar
    BLOOD, 2021, 138
  • [2] Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients
    Arcaini, Luca
    Merli, Michele
    Passamonti, Francesco
    Rizzi, Silvia
    Ferretti, Virginia
    Rattotti, Sara
    Pascutto, Cristiana
    Paulli, Marco
    Lazzarino, Mario
    BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 (03) : 455 - 457
  • [3] External Validation of the FLIPI Risk Score Measured at Diagnosis and POD24 Among Individuals With Follicular Lymphoma at the Time of Subsequent Relapse
    Boyne, Devon J.
    Chua, Neil
    Owen, Carolyn
    Joe-Uzuegbu, Ofodile
    Shakir, Huma
    Gogna, Priyanka
    Jarada, Tamer N.
    Brenner, Darren R.
    Elia-Pacitti, Julia
    Ewara, Emmanuel M.
    Cheung, Winson Y.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (09): : e277 - e285
  • [4] External Validation of the FLIPI Risk Score Measured at Initial Diagnosis and POD24 Among Previously Treated Individuals with Progressed Follicular Lymphoma in Alberta, Canada
    Owen, Carolyn
    Chua, Neil
    Boyne, Devon
    Joe-Uzuegbu, Ofodile
    Shakir, Huma
    Gonga, Priyanka
    Brenner, Darren
    Elia-Pacitti, Julia
    Ewara, Emmanuel
    Cheung, Winson Y.
    BLOOD, 2022, 140 : 8024 - 8025
  • [5] First external validation of the FLIPI-L score in a single-center series of patients with follicular lymphoma
    Mozas, Pablo
    Rivero, Andrea
    Rivas-Delgado, Alfredo
    Correa, Juan Gonzalo
    Condom, Maria
    Nadeu, Ferran
    Gine, Eva
    Delgado, Julio
    Villamor, Neus
    Campo, Elias
    Magnano, Laura
    Lopez-Guillermo, Armando
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (02) : 297 - 301
  • [6] Neither the FLIPI Nor the FLIPI2 Accurately Segregates Low- Risk From Intermediate- Risk Follicular Lymphoma Patients in Terms of Progression-Free Survival
    El-Najjar, Inas
    Matthews, Janet
    Gribben, John
    Montoto, Silvia
    BLOOD, 2011, 118 (21) : 1144 - 1144
  • [7] Epcoritamab SC With Rituximab plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma, Including Patients With POD24: Updated Results From EPCORE NHL-2
    Merryman, Reid W.
    Belada, David
    Sureda, Anna
    Leppa, Sirpa
    Vermaat, Joost S. P.
    Holte, Harald
    Hutchings, Martin
    Lugtenburg, Pieternella
    de Vos, Sven
    Abrisqueta, Pau
    Nijland, Marcel
    Christensen, Jacob Haaber
    Wahlin, Bjorn E.
    Linton, Kim M.
    Wang Liwei
    Abbas, Aqeel
    Rana, Ali
    Quadri, Syed
    Falchi, Lorenzo
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S37 - S38
  • [8] Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in Follicular Lymphoma: Results from the Follicular Lymphoma Analysis of Surrogacy Hypothesis (FLASH) Investigation Using Individual Data from 5,453 Patients on 13 Clinical Trials
    Casulo, Carla
    Le-Rademacher, Jennifer
    Dixon, Jesse
    Salles, Gilles
    Hoster, Eva
    Herold, Michael
    Hiddemann, Wolfgang
    Sebban, Catherine
    Marcus, Robert
    Kimby, Eva
    Hochster, Howard
    Vitolo, Umberto
    Gyan, Emmanuel
    Ou, Fang-Shu
    Nielsen, Tina
    Foon, Kenneth A.
    Shi Qiuan
    Flowers, Christopher
    BLOOD, 2017, 130
  • [9] Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)
    Moccia, Alden Alberto
    Schaer, Saemi
    Hayoz, Stefanie
    Pirosa, Maria Cristina
    Taverna, Christian
    Novak, Urban
    Kimby, Eva
    Ghielmini, Michele
    Zucca, Emanuele
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 192 (06) : 1031 - 1034
1